Damon C. Smith

Founder at TALLC Corp., Inc.

Health Technology

Consumer Services

Profile

Damon C.
Smith is the founder of TALLC Corp., Inc. He worked as a Senior Vice President of Research & Development at Labopharm, Inc., a Development Director at Therapeutics Antibodies, Inc., a Research Director at ConjuChem, Inc., and an Executive Director of Development at Protherics Plc.
Dr. Smith received his undergraduate and doctorate degrees from the University of Essex.

Damon C. Smith active positions

Companies	Position	Start
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Founder	-

All active positions of Damon C. Smith

Former positions of Damon C. Smith

Companies	Position	End
Therapeutics Antibodies, Inc.	Corporate Officer/Principal	-
ConjuChem, Inc. ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides.	Chief Tech/Sci/R&D Officer	-
Protherics Plc Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK.	Corporate Officer/Principal	-
Labopharm, Inc. Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada.	Chief Tech/Sci/R&D Officer	-

See the detail of Damon C. Smith's experience

Training of Damon C. Smith

University of Essex

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Damon C. Smith's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Protherics Plc Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK.	Health Technology
ConjuChem, Inc. ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides.	Health Technology
Labopharm, Inc. Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada.	Health Technology
Therapeutics Antibodies, Inc.
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Health Technology

See company connections

Stock Market
Insiders
Damon C. Smith